Abd Ellah et al. Oxidative stress and bovine liver diseases: role of glutathione peroxydase and glucose 6-phosphate dehydrogenase. Jpn J Vet Res 2007; 54:163-173.
Alfarouk et al. Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question. Oncoscience, 2014, 1: 777-802.
Bhatt et al. Cancer biomarkers – Current perspectives. Indian J Med Res, 2010, 132: 129-149.
Bonomini et al. Metabolic syndrome, aging and involvement of oxidative stress. Aging Dis. 2015, 6:109-20.
Chen et al. The Warburg effect: evolving interpretations of an established concept. Free Radic Biol Med. 2015
Choi et al. Translocator protein (18 kDa)/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated state. Glia, 2011, 59:219–230.
Christensen et al. Comparison of serum amyloid A and C-reactive protein as diagnostic markers of systemic inflammation in dogs. CVJ 2014, 55:161-168.
Conley. New tools bring greater understanding to cellular metabolism research. DDW 2014, 3: 43-53.
Cuezva et al. The bioenergetic signature of cancer: A marker of tumor progression. Cancer research, 2002, 62:6674–6681.
Dykens & Will. The significance of mitochondrial toxicity testing in drug development. Drug Discovery Today, 2007 , 12:777-85.
Federico et al. Mitochondria, oxidative stress and neurodegeneration. J Neurol Sciences, 2012, 322: 254–262.
Frantz & Wipf, Mitochondria as a target in treatment. Environ Mol Mutagen. 2010, 51: 462–475.
Geldenhuis et al. mitoNEET as a novel drug target for mitochondrial dysfunction. Drug Discovery Today, 2014, 19: 1601-1610.
Ghys et al. Cystatin C: a new renal marker and its potential use in small animal medicine. J Vet Intern Med 2014, 28:1152-1164.
Giordano et al. Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease. Redox Biol. 2013, 2:82-90.
Giovannucci. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr. 2007, 86:s836-42.
Hameed & Hsiung. The role of mitochondria in aging, neurodegenerative disease and future therapies. BCMJ, 2011, 54:188-192.
Hardie. AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes (Lond). 2008, 32 Suppl 4:S7-12.
Hinder et al. Decreased glycolytic and tricarboxylic acid cycle intermediates coincide with peripheral nervous system oxidative stress in a murine model of type 2 diabetes. J Endocrinol 2013, 216:1-11.
Hopps & Caimi. Protein oxidation in metabolic syndrome. Clin Invest Med, 2013,36:E1-E8.
Indo et al. A mitochondrial superoxide theory for oxidative stress diseases and aging. J Clin Biochem Nutr. 2015, 56:1-7.
Jomova & Valko. Advances in metal-induced oxidative stress and human disease. Toxicology. 2011, 283:65-87
Kirchvink et al. The oxidant/antioxidant equilibrium in horses. Vet J 2007
Mantovani A et al. Cancer-related inflammation. Nature. 2008, 454:436-44.
Marzetti et al. Role of mitochondrial dysfunction and altered autophagy in cardiovascular aging and disease: from mechanisms to therapeutics. Am J Physiol Heart Circ Physiol. 2013, 305:H459-76.
Menendez & Lupu. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007, 7:763-77.
Nicolson. Mitochondrial dysfunction and chronic disease: treatment with natural supplements. Altern Ther Health Med. 2014, 20 (suppl 1):18-25.
Nowotny et al. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules. 2015, 5:194-222.
Ospina et al. Using no esterified fatty acids and beta-hydroxybutyrate concentrations during the transition period for herd-level monitoring of increased risks of disease and decreased reproductive and milking performances. Vet Clin Food Anim 2013, 29:327-412.
Owens et al. Acidosis in cattle: a review. J Anim Sci 1998, 76:275-286.
Peireira et al. Investigating drug-induced mitochondrial toxicity: A biosensor to increase drug safety? Current Drug Safety, 2009, 4, 34-54.
Pihl et al. Serum amyloid A and haptoglobin concentrations in serum and peritoneal fluid of healthy horses and horses with acute abdominal pain. Vet Clin Pathol 2013, 42:177-183.
Polsky & Ellis. Obesity, insulin resistance, and type 1 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes. 2015, 22:277-82.
Rodriguez et al. Oxidative stress in veterinary medicine. Vet Med Int 2011.
Rodriguez-Enriquez et al. Canonical and new generation anticancer drugs also target energy metabolism. Arch Toxicol 2014, 88:1327-1350.
Sanz & Stefanatos. The mitochondrial free radical theory of aging: a critical view. Curr Aging Sci. 2008 Mar;1(1):10-21.
Sewczyk & Wojtczak. Mitochondria as a pharmacoligical target. Pharm Rev 2002, 54:101-127.
Shinmura. Effects of caloric restriction on cardiac oxidative stress and mitochondrial bioenergetics: potential role of cardiac sirtuins. Oxid Med Cell Longev. 2013, 528: 935
Sridhar et al. Emerging links between type 2 diabetes and Alzheimer’s disease. World J Diabetes. 2015, 6:744-51
Sotgia et al. Cancer metabolism: new validated targets for drug discovery. Oncotarget 2013, 4:1309-1316.
Sultana et al. Biomarkers of oxidative stress in neurodegenerative diseases. Molecular basis of oxidative stress: chemistry, mechanisms, and disease pathogenesis. Villamena Ed, 2013.
Tardif. Oxidative stress and coronary heart disease. Cardiology rounds, 2003, 7.
Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes. 2015, 6:456-80.
Tothova et al. Acute phase proteins and their use in the diagnosis of diseases in ruminants: a review. Vet Medicina 2014, 59:163-180.
Vernon. Inborn Errors of Metabolism: Advances in Diagnosis and Therapy. JAMA Pediatr. 2015.
Yara et al. Oxidative stress and DNA methylation regulation in the metabolic syndrome. Epigenomics. 2015, 7:283-300.